This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This VGLL4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 136-163 amino acids from the Central region of human VGLL4.
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Haltbarkeit
6 months
Trynka, Zhernakova, Romanos, Franke, Hunt, Turner, Bruinenberg, Heap, Platteel, Ryan, de Kovel, Holmes, Howdle, Walters, Sanders, Mulder, Mearin, Verbeek, Trimble, Stevens, Kelleher, Barisani et al.: "Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. ..." in: Gut, Vol. 58, Issue 8, pp. 1078-83, (2009) (PubMed).
Chen, Mullett, Stewart: "Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes." in: The Journal of biological chemistry, Vol. 279, Issue 29, pp. 30800-6, (2004) (PubMed).
DKFZp459C0333 antikoerper, VGL-4 antikoerper, BC048841 antikoerper, vestigial-like family member 4 antikoerper, vestigial like family member 4 antikoerper, Vgll4 antikoerper, VGLL4 antikoerper
Hintergrund
VGLL4 may act as a specific coactivator for the mammalian TEFs (By similarity).